RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor
The DOI matches its Crossref record; 27 of the 27 references it cites were found in a registry or an index.
Abstract
Calcitonin-gene-related peptide (CGRP) and adrenomedullin are related peptides with distinct pharmacological profiles. Here we show that a receptor with seven transmembrane domains, the calcitonin-receptor-like receptor (CRLR), can function as either a CGRP receptor or an adrenomedullin receptor, depending on which members of a new family of single-transmembrane-domain proteins, which we have called receptor-activity-modifying proteins or RAMPs, are expressed. RAMPs are required to transport CRLR to the plasma membrane. RAMP1 presents the receptor at the cell surface as a mature glycoprotein and a CGRP receptor. RAMP2-transported receptors are core-glycosylated and are adrenomedullin receptors.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“For several years, CRLR was an”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [146]
In the citing paper
“Dimerization of CRLR with RAMP1 forms a specific, highaffinity receptor for CGRP, whereas CRLR dimerization with either RAMP2 or RAMP3 produces receptors with high affinity to adrenomedullin (146).”
From The Activity of Peptides of the Calcitonin Family in Bone (2019) · cites this paper as [146]
In the citing paper
“CRLR by itself cannot function as a receptor for CGRP as it needs to form complexes with accessory proteins from the RAMP family134.”
From Neuropeptides Substance P and Calcitonin Gene Related Peptide Accelerate the Development and Fibrogenesis of Endometriosis (2019) · cites this paper as [134]
In the citing paper
“while for CGRP, its major receptors are calcitonin receptor like receptor (CRLR) and receptor activity modifying protein 1 (RAMP-1).”
From Neuropeptides Substance P and Calcitonin Gene Related Peptide Accelerate the Development and Fibrogenesis of Endometriosis (2019) · cites this paper as [134]
Citations
Cites
Ponath, P. D., Qin, S., Post, T. W., Wang, J., Wu, L., Gerard, N. P., Newman, W., Gerard, C., & Mackay, C. R. (1996) · The Journal of experimental medicine · doi:10.1084/jem.183.6.2437 · Cited by 612 · cited 1×
“Many receptors are not easily expressed in commonly used host cell lines: GABA b , eotaxin (CKR3”
BackgroundChang, C.-P., Pearse, R. V., O'Connell, S., & Rosenfeld, M. G. (1993) · Neuron · doi:10.1016/0896-6273(93)90230-o · Cited by 537
Teasdale, R. D., & Jackson, M. R. (1996) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.12.1.27 · Cited by 500 · cited 1×
“This pair of basic residues is similar to an endoplasmic-reticulum-retrieval moti”
BackgroundExpression Cloning of an Adenylate Cyclase-Coupled Calcitonin Receptor
Lin, H. Y., Harris, T. L., Flannery, M. S., Aruffo, A., Kaji, E. H., Gorn, A., Kolakowski, L. F., Lodish, H. F., & Goldring, S. R. (1991) · Science · doi:10.1126/science.1658940 · Cited by 451
A cDNA Encoding the Calcitonin Gene-related Peptide Type 1 Receptor
Aiyar, N., Rand, K., Elshourbagy, N. A., Zeng, Z., Adamou, J. E., Bergsma, D. J., & Li, Y. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.19.11325 · Cited by 320
Cloning and Expression of cDNA Encoding a Rat Adrenomedullin Receptor
Kapas, S., Catt, K. J., & Clark, A. J. L. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.43.25344 · Cited by 288 · cited 1×
“Two related members of the ‘family A’ class of GPCRs, RDC1 and G10D, were then identified as receptors for CGRP and ADM, respectivel”
BackgroundCalcitonin gene-related peptide: Multiple actions, multiple receptors
Poyner, D. R. (1992) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(92)90036-y · Cited by 225 · cited 1×
“These activities include the regulation of neuromuscular junctions, of antigen presentation within the immune system, of vascular tone and of sensory neurotransmissio”
BackgroundWang, X., Yue, T. L., Barone, F. C., White, R. F., Clark, R. K., Willette, R. N., Sulpizio, A. C., Aiyar, N. V., Ruffolo, R. R., & Feuerstein, G. Z. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11480 · Cited by 191 · cited 1×
“and its messenger RNA is upregulated in CNS tissues that are subject to ischaemi”
BackgroundIdentification of an Orphan Receptor Gene as a Type 1 Calcitonin Gene-Related Peptide Receptor
Kapas, S., & Clark, A. J. L. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2847 · Cited by 175
Muff, R., Born, W., & Fischer, J. A. (1995) · European Journal of Endocrinology · doi:10.1530/eje.0.1330017 · Cited by 155
Cited by
Pierce, K. L., Premont, R. T., & Lefkowitz, R. J. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm908 · Cited by 2,701
Pathophysiology of migraine: a disorder of sensory processing
Goadsby, P. J., Holland, P. R., Martins-Oliveira, M., Hoffmann, J., Schankin, C., & Akerman, S. (2017) · Physiological Reviews · doi:10.1152/physrev.00034.2015 · Cited by 1,998
“CGRP acts at two receptors: one, the so-called canonical CGRP-receptor complex, is made up of a G protein-coupled receptor consisting of a seven transmembrane spanning protein (calcitonin receptor-like receptor; CLR) and a single transmembrane receptor modifying protein (RAMP) 1 (16, 593).”
BackgroundFerguson, S. S. G. (2001) · Pharmacological Reviews · doi:10.1016/s0031-6997(24)01478-9 · Cited by 1,826
Molecular tinkering of G protein-coupled receptors: an evolutionary success
Bockaert, J. (1999) · The EMBO Journal · doi:10.1093/emboj/18.7.1723 · Cited by 1,550
“…disturbing for pharmacologists is the report that CRLR is a virtual receptor which will generate the CGRP (calcitonin gene-related peptide) receptor when associated with RAMP1 (receptoractivity-modifying protein) and the adrenomedullin receptor when associated with RAMP2 (McLatchie et al., 1998).”
BackgroundBurns, J. M., Summers, B. C., Wang, Y., Melikian, A., Berahovich, R., Miao, Z., Penfold, M. E. T., Sunshine, M. J., Littman, D. R., Kuo, C. J., et al. (2006) · The Journal of Experimental Medicine · doi:10.1084/jem.20052144 · Cited by 1,263
Uncovering Molecular Mechanisms Involved in Activation of G Protein-Coupled Receptors
Gether, U. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.1.0390 · Cited by 1,263
“While RAMP1 converted CRLR into a calcitonin-gene-related-peptide (CGRP) receptor, RAMP2-associated receptors display the properties of an adrenomedullin receptor (282).”
BackgroundCalcitonin Gene-Related Peptide: Physiology and Pathophysiology
Russell, F. A., King, R., Smillie, S.-J., Kodji, X., & Brain, S. D. (2014) · Physiological Reviews · doi:10.1152/physrev.00034.2013 · Cited by 1,258
“The RAMP family of proteins is comprised of three members: RAMP1, RAMP2, and RAMP3, each with Ͻ30% sequence homology but sharing a similar structure.”
BackgroundInfluentialGABAB-receptor subtypes assemble into functional heteromeric complexes
Kaupmann, K., Malitschek, B., Schuler, V., Heid, J., Froestl, W., Beck, P., Mosbacher, J., Bischoff, S., Kulik, A., Shigemoto, R., et al. (1998) · Nature · doi:10.1038/25360 · Cited by 1,195
Heterodimerization is required for the formation of a functional GABAB receptor
White, J. H., Wise, A., Main, M. J., Green, A., Fraser, N. J., Disney, G. H., Barnes, A. A., Emson, P., Foord, S. M., & Marshall, F. H. (1998) · Nature · doi:10.1038/25354 · Cited by 1,182
Self-citationA Spatial Map of Olfactory Receptor Expression in the Drosophila Antenna
Vosshall, L. B., Amrein, H., Morozov, P. S., Rzhetsky, A., & Axel, R. (1999) · Cell · doi:10.1016/s0092-8674(00)80582-6 · Cited by 1,177
“…1998] and perhaps the ability of an odorant to activate a combination of glomeruli allows for the discrimination of a diverse arrayeven RAMPs [McLatchie et al., 1998] and rho [Mitchell et al., 1998]) that may govern the choice of one family of odors far exceeding the number of receptors and…”
BackgroundModels and Mechanisms of Hyperalgesia and Allodynia
Sandkühler, J. (2009) · Physiological Reviews · doi:10.1152/physrev.00025.2008 · Cited by 1,148
GABAB receptors function as a heteromeric assembly of the subunits GABABR1 and GABABR2
Jones, K. A., Borowsky, B., Tamm, J. A., Craig, D. A., Durkin, M. M., Dai, M., Yao, W.-J., Johnson, M., Gunwaldsen, C., Huang, L.-Y., et al. (1998) · Nature · doi:10.1038/25348 · Cited by 1,079
“The recent cloning of the genes encoding a family of accessory proteins that modify the binding and functional properties of a calcitonin-receptor-like recepto”
BackgroundKieffer, T. J., & Francis Habener, J. (1999) · Endocrine Reviews · doi:10.1210/edrv.20.6.0385 · Cited by 1,062
Islet Amyloid Polypeptide, Islet Amyloid, and Diabetes Mellitus
Westermark, P., Andersson, A., & Westermark, G. T. (2011) · Physiological Reviews · doi:10.1152/physrev.00042.2009 · Cited by 1,044
“For example, they participate in transport of receptor protein to the cell surface, influence glycosylation (241), and modulate signaling (252).”
BackgroundA New ER Trafficking Signal Regulates the Subunit Stoichiometry of Plasma Membrane KATP Channels
Zerangue, N., Schwappach, B., Jan, Y. N., & Jan, L. Y. (1999) · Neuron · doi:10.1016/s0896-6273(00)80708-4 · Cited by 1,025
“Surprisingly, we find that tional subunits for surface expression (Geering, 1990; the rate-limiting quality control mechanism during KATP McLatchie et al., 1998; White et al., 1998). assembly does not involve degradation or ER folding–”
BackgroundCGRP as the target of new migraine therapies — successful translation from bench to clinic
Edvinsson, L., Haanes, K. A., Warfvinge, K., & Krause, D. N. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0003-1 · Cited by 999
G Protein-Coupled Receptor Allosterism and Complexing
Christopoulos, A., & Kenakin, T. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.323 · Cited by 931
“Although RAMPs have been implicated in the trafficking of receptors to the cell membrane and the regulation of the glycosylation pattern (McLatchie et al., 1998; Foord and Marshall, 1999; Fraser et al., 1999), there are effects of RAMPs, particularly RAMP3, that cannot be explained by simple…”
BackgroundInfluentialMolecular Structure and Physiological Functions of GABABReceptors
Bettler, B., Kaupmann, K., Mosbacher, J., & Gassmann, M. (2004) · Physiological Reviews · doi:10.1152/physrev.00036.2003 · Cited by 924
“The discovery that receptor activity modifying proteins (RAMPs) can change the pharmacology of a GPCR triggered an intense search for GABAB receptor-associated proteins (221).”
BackgroundPoyner, D. R., Sexton, P. M., Marshall, I., Smith, D. M., Quirion, R., Born, W., Muff, R., Fischer, J. A., & Foord, S. M. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.233 · Cited by 804
“The important breakthrough came when an expression cloning approach demonstrated that the CL receptor required a single transmembrane domain protein, termed receptor activity modifying protein, RAMP1, to function as a CGRP receptor (McLatchie et al., 1998) (Fig.”
BackgroundInfluentialSelf-citationVascular Actions of Calcitonin Gene-Related Peptide and Adrenomedullin
Brain, S. D., & Grant, A. D. (2004) · Physiological Reviews · doi:10.1152/physrev.00037.2003 · Cited by 765
“single transmembrane domain proteins (248).”
BackgroundAdrenomedullin, a Multifunctional Regulatory Peptide*
Hinson, J. P., Kapas, S., & Smith, D. M. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.2.0396 · Cited by 752
“ilar to that of CGRP receptors in SK-N-MC cells (186).”
BackgroundInfluentialMechanisms of signalling and biased agonism in G protein-coupled receptors
Wootten, D., Christopoulos, A., Marti-Solano, M., Babu, M. M., & Sexton, P. M. (2018) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-018-0049-3 · Cited by 724
Kirk, P., Wilson, M. C., Heddle, C., Brown, M. H., Barclay, A. N., & Halestrap, A. P. (2000) · The EMBO Journal · doi:10.1093/emboj/19.15.3896 · Cited by 700
Retinylidene Proteins: Structures and Functions from Archaea to Humans
Spudich, J. L., Yang, C.-S., Jung, K.-H., & Spudich, E. N. (2000) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.16.1.365 · Cited by 675
Molecular detection of pheromone signals in mammals: from genes to behaviour
Dulac, C., & Torello, A. T. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1140 · Cited by 660
Oligomerization of G-protein-coupled transmitter receptors
Bouvier, M. (2001) · Nature Reviews Neuroscience · doi:10.1038/35067575 · Cited by 669
“Several years later, using an expression-cloning approach in oocytes, McLatchie et al.(99) isolated a new gene product”
MethodNeuronal Control of Skin Function: The Skin as a Neuroimmunoendocrine Organ
Roosterman, D., Goerge, T., Schneider, S. W., Bunnett, N. W., & Steinhoff, M. (2006) · Physiological Reviews · doi:10.1152/physrev.00026.2005 · Cited by 665
RTP Family Members Induce Functional Expression of Mammalian Odorant Receptors
Saito, H., Kubota, M., Roberts, R. W., Chi, Q., & Matsunami, H. (2004) · Cell · doi:10.1016/j.cell.2004.11.021 · Cited by 613
Bowery, N. G., Bettler, B., Froestl, W., Gallagher, J. P., Marshall, F., Raiteri, M., Bonner, T. I., & Enna, S. J. (2002) · Pharmacological Reviews · doi:10.1124/pr.54.2.247 · Cited by 601
“trafficking protein, such as a RAMP (receptor activity modifying protein) (McLatchie et al., 1998), might be required for the efficient functional expression of the GABAB site.”
BackgroundDimerization: An Emerging Concept for G Protein–Coupled Receptor Ontogeny and Function
Angers, S., Salahpour, A., & Bouvier, M. (2002) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.42.091701.082314 · Cited by 586
“(48) identified a single transmembrane protein that is essential for the ER export o f a 7 transmembrane domain receptor known as the calcitonin-receptor-like receptor (CRLR).”
BackgroundBecker, K. L., Nylén, E. S., White, J. C., Müller, B., & Snider, R. H. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2002-021444 · Cited by 578
The Concise Guide to PHARMACOLOGY 2013/14: G Protein‐Coupled Receptors
Alexander, S. P. H., Benson, H. E., Faccenda, E., Pawson, A. J., Sharman, J. L., Spedding, M., Peters, J. A., Harmar, A. J., & Collaborators, C. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12445 · Cited by 556
Integrating the Molecular and Cellular Basis of Odor Coding in the Drosophila Antenna
Dobritsa, A. A., van der Goes van Naters, W., Warr, C. G., Steinbrecht, R. A., & Carlson, J. R. (2003) · Neuron · doi:10.1016/s0896-6273(03)00094-1 · Cited by 553
Schuler, V., Lüscher, C., Blanchet, C., Klix, N., Sansig, G., Klebs, K., Schmutz, M., Heid, J., Gentry, C., Urban, L., et al. (2001) · Neuron · doi:10.1016/s0896-6273(01)00345-2 · Cited by 538
“…where coexpression of RAMPs, a family of single membrane spanning domain proteins, drasticallycium channel activity, thereby controlling presynaptic alters the pharmacological profile of the G protein-cou-transmitter release and postsynaptic silencing of excitpled receptor (McLatchie et al., 1998).”
BackgroundCGRP and its receptors provide new insights into migraine pathophysiology
Ho, T. W., Edvinsson, L., & Goadsby, P. J. (2010) · Nature Reviews Neurology · doi:10.1038/nrneurol.2010.127 · Cited by 523
Christopoulos, G., Perry, K. J., Morfis, M., Tilakaratne, N., Gao, Y., Fraser, N. J., Main, M. J., Foord, S. M., & Sexton, P. M. (1999) · Molecular Pharmacology · doi:10.1124/mol.56.1.235 · Cited by 486
“235 at A SPE T Journals on July 6, 2017 m olpharm .aspetjournals.org D ow nloaded from ing proteins (RAMPs), which was comprised of three members designated RAMP 1, RAMP 2, and RAMP 3.”
InfluentialSelf-citationFine-tuning of GPCR activity by receptor-interacting proteins
Ritter, S. L., & Hall, R. A. (2009) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2803 · Cited by 480
Bulenger, S., Marullo, S., & Bouvier, M. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.01.004 · Cited by 448
Physiological Regulation of G Protein-Linked Signaling
Morris, A. J., & Malbon, C. C. (1999) · Physiological Reviews · doi:10.1152/physrev.1999.79.4.1373 · Cited by 449
The nervous system and innate immunity: the neuropeptide connection
Brogden, K. A., Guthmiller, J. M., Salzet, M., & Zasloff, M. (2005) · Nature Immunology · doi:10.1038/ni1209 · Cited by 446
“Structural and biological characterization of chromofungin, the antifungal chromogranin A (47-66)-derived peptide.”
Roh, J., Chang, C. L., Bhalla, A., Klein, C., & Hsu, S. Y. T. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m305332200 · Cited by 443
Single-Cell RNA Sequencing of Lymph Node Stromal Cells Reveals Niche-Associated Heterogeneity
Rodda, L. B., Lu, E., Bennett, M. L., Sokol, C. L., Wang, X., Luther, S. A., Barres, B. A., Luster, A. D., Ye, C. J., & Cyster, J. G. (2018) · Immunity · doi:10.1016/j.immuni.2018.04.006 · Cited by 438
“The MRCs also expressed embigin (Emb), which has roles in nerve terminal sprouting (Table S3; Lain et al., 2009).”
InfluentialMetherell, L. A., Chapple, J. P., Cooray, S., David, A., Becker, C., Rüschendorf, F., Naville, D., Begeot, M., Khoo, B., Nürnberg, P., et al. (2005) · Nature Genetics · doi:10.1038/ng1501 · Cited by 437
“MRAP joins a group of small single–transmembrane domain proteins that include the RAMP proteins, which support expression of the calcitonin and calcitonin-like receptor”
BackgroundThe Parabrachial Nucleus: CGRP Neurons Function as a General Alarm
Palmiter, R. D. (2018) · Trends in Neurosciences · doi:10.1016/j.tins.2018.03.007 · Cited by 431
Ouhara, K., Komatsuzawa, H., Yamada, S., Shiba, H., Fujiwara, T., Ohara, M., Sayama, K., Hashimoto, K., Kurihara, H., & Sugai, M. (2005) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dki103 · Cited by 428
Principles: Receptor theory in pharmacology
Kenakin, T. (2004) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2004.02.012 · Cited by 412
Odorant Receptor Expression Defines Functional Units in the Mouse Olfactory System
Bozza, T., Feinstein, P., Zheng, C., & Mombaerts, P. (2002) · The Journal of Neuroscience · doi:10.1523/jneurosci.22-08-03033.2002 · Cited by 412
“…may be affected by variation in OR expression level, modulation of signal transduction pathways (Schild and Restrepo, 1998), differential expression of auxiliary proteins that may effect ligand binding (McLatchie et al., 1998), or differences in spare-receptor capacity (Cleland and Linster, 1999).”
BackgroundThe Significance of Vasoactive Intestinal Peptide in Immunomodulation
Delgado, M., Pozo, D., & Ganea, D. (2004) · Pharmacological Reviews · doi:10.1124/pr.56.2.7 · Cited by 412
“, 2003), resulting in alterations of receptor phenotype or pharmacological profile (McLatchie et al., 1998).”
BackgroundInverse, protean, and ligand‐selective agonism: matters of receptor conformation
KENAKIN, T. (2001) · The FASEB Journal · doi:10.1096/fj.00-0438rev · Cited by 408
Amylin: Pharmacology, Physiology, and Clinical Potential
Hay, D. L., Chen, S., Lutz, T. A., Parkes, D. G., & Roth, J. D. (2015) · Pharmacological Reviews · doi:10.1124/pr.115.010629 · Cited by 400
“It is also important to point out that RAMPs have several other GPCR partners, so their expression is only indicative of a potential interaction with the calcitonin receptor (McLatchie et al., 1998; Christopoulos et al., 2003; Harikumar et al., 2009; Lenhart et al., 2013).”
BackgroundNeugebauer, V. (2015) · Handbook of Experimental Pharmacology · doi:10.1007/978-3-662-46450-2_13 · Cited by 399
“Functional CGRP1 receptors are formed by a heterodimeric complex of the calcitonin receptor-like receptor (CRLR) and receptor activity-modifying protein 1 (RAMP1) (Robinson et al. 2009;McLatchie et al. 1998).”
BackgroundThe Sigma Receptor as a Ligand-Regulated Auxiliary Potassium Channel Subunit
Aydar, E., Palmer, C. P., Klyachko, V. A., & Jackson, M. B. (2002) · Neuron · doi:10.1016/s0896-6273(02)00677-3 · Cited by 398
A role for heterodimerization of μ and δ opiate receptors in enhancing morphine analgesia
Gomes, I., Gupta, A., Filipovska, J., Szeto, H. H., Pintar, J. E., & Devi, L. A. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0307601101 · Cited by 388
CGRP physiology, pharmacology, and therapeutic targets: migraine and beyond
Russo, A. F., & Hay, D. L. (2023) · Physiological Reviews · doi:10.1152/physrev.00059.2021 · Cited by 382
Mechanisms of peptide and nonpeptide ligand binding to Class B G-protein-coupled receptors
Hoare, S. R. J. (2005) · Drug Discovery Today · doi:10.1016/s1359-6446(05)03370-2 · Cited by 379
Update on the pharmacology of calcitonin/CGRP family of peptides: IUPHAR Review 25
Hay, D. L., Garelja, M. L., Poyner, D. R., & Walker, C. S. (2018) · British Journal of Pharmacology · doi:10.1111/bph.14075 · Cited by 370
“Unresolved questions, challenges and recommendations Since the identification that RAMPs are required for the formation of AM, CGRP and amylin receptors, great strides have been made in understanding their biology (McLatchie et al., 1998; Christopoulos et al., 1999).”
BackgroundInfluentialThe 7 TM G‐Protein‐Coupled Receptor Target Family
Jacoby, E., Bouhelal, R., Gerspacher, M., & Seuwen, K. (2006) · ChemMedChem · doi:10.1002/cmdc.200600134 · Cited by 359
Target validation of G-protein coupled receptors
Wise, A., Gearing, K., & Rees, S. (2002) · Drug Discovery Today · doi:10.1016/s1359-6446(01)02131-6 · Cited by 359
Self-citationRegulation of GPCR activity, trafficking and localization by GPCR‐interacting proteins
Magalhaes, A. C., Dunn, H., & Ferguson, S. S. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2011.01552.x · Cited by 353
“RAMPs appear to allosterically influence the structure of calcitonin family receptors allowing for their terminal glycosylation in the endoplasmic reticulum, thereby facilitating their expression at the cell surface (McLatchie et al., 1998) (Figure 2).”
BackgroundInfluentialCaron, K. M., & Smithies, O. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.98.2.615 · Cited by 346
PDZ Domain Suppression of an ER Retention Signal in NMDA Receptor NR1 Splice Variants
Standley, S., Roche, K. W., McCallum, J., Sans, N., & Wenthold, R. J. (2000) · Neuron · doi:10.1016/s0896-6273(00)00161-6 · Cited by 346
Modern Aspects of Cutaneous Neurogenic Inflammation
Steinhoff, M., Ständer, S., Seeliger, S., Ansel, J. C., Schmelz, M., & Luger, T. (2003) · Archives of Dermatology · doi:10.1001/archderm.139.11.1479 · Cited by 346
GABAB receptors – the first 7TM heterodimers
Marshall, F. H., Jones, K. A., Kaupmann, K., & Bettler, B. (1999) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(99)01383-8 · Cited by 345
Mutant G-protein-coupled receptors as a cause of human diseases
Schöneberg, T., Schulz, A., Biebermann, H., Hermsdorf, T., Römpler, H., & Sangkuhl, K. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.08.008 · Cited by 337
Evans, B. N., Rosenblatt, M. I., Mnayer, L. O., Oliver, K. R., & Dickerson, I. M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m005604200 · Cited by 337
Eftekhari, S., Salvatore, C. A., Calamari, A., Kane, S. A., Tajti, J., & Edvinsson, L. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.05.016 · Cited by 329
“RAMP1 is involved in receptor trafficking and is required for CGRP binding to CLR, whereas the interaction of CLR with other RAMP proteins, RAMP2 or RAMP3, forms adrenomedullin receptors (McLatchie et al., 1998, Foord and Marshall, 1999, Zhang et al., 2007).”
The Role of the CXCL12/CXCR4/CXCR7 Chemokine Axis in Cancer
Shi, Y., Riese, D. J., & Shen, J. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.574667 · Cited by 336
“Moreover, CXCR7 overexpression and gene silencing in tumor cells collectively support the role of CXCR7 contribution to tumor growth (Miao et al., 2007; Meijer et al., 2008).”
BackgroundPathobiochemistry and clinical use of procalcitonin
Meisner, M. (2002) · Clinica Chimica Acta · doi:10.1016/s0009-8981(02)00101-8 · Cited by 333
Choi, J. E., & Di Nardo, A. (2018) · Seminars in Immunopathology · doi:10.1007/s00281-018-0675-z · Cited by 331
“tor (GPCR), neurokinin (NK)-1 receptor for SP, and the CGRP receptor complex for CGRP [31, 32].”
Neuropeptides: opportunities for drug discovery
Hökfelt, T., Bartfai, T., & Bloom, F. (2003) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00482-4 · Cited by 328
Lennerz, J. K., Rühle, V., Ceppa, E. P., Neuhuber, W. L., Bunnett, N. W., Grady, E. F., & Messlinger, K. (2008) · Journal of Comparative Neurology · doi:10.1002/cne.21607 · Cited by 325
“In the CGRP receptor complex the CLR component is associated with RAMP1, whereas in the AMD receptor complex the CLR is coupled with RAMP2 or RAMP3 (McLatchie et al., 1998).”
BackgroundAgnati, L. F., Ferré, S., Lluis, C., Franco, R., & Fuxe, K. (2003) · Pharmacological Reviews · doi:10.1124/pr.55.3.2 · Cited by 323
“This was the way the RAMP1 was discovered (McLatchie et al., 1998).”
BackgroundInfluentialTerrillon, S., Durroux, T., Mouillac, B., Breit, A., Ayoub, M. A., Taulan, M., Jockers, R., Barberis, C., & Bouvier, M. (2003) · Molecular Endocrinology · doi:10.1210/me.2002-0222 · Cited by 322
Drug Efficacy at G Protein–Coupled Receptors
Kenakin, T. (2002) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.42.091401.113012 · Cited by 316
Differential Compartmentalization and Distinct Functions of GABAB Receptor Variants
Vigot, R., Barbieri, S., Bräuner-Osborne, H., Turecek, R., Shigemoto, R., Zhang, Y.-P., Luján, R., Jacobson, L. H., Biermann, B., Fritschy, J.-M., et al. (2006) · Neuron · doi:10.1016/j.neuron.2006.04.014 · Cited by 314
“…or pharmacological differences in vitro, suggested the existence of auxiliary proteins that modify receptor activity, pharmacology, and localization (Marshall et al., 1999; Mohler and Fritschy, 1999), precedence for which is found with other G protein-coupled receptors (McLatchie et al., 1998).”
BackgroundProcalcitonin in sepsis and systemic inflammation: a harmful biomarker and a therapeutic target
Becker, K. L., Snider, R., & Nylen, E. S. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2009.00433.x · Cited by 309
“Both CT and CGRP act via a group of receptors that are formed by complexes between the receptors (‘calcitonin receptor’ and ‘calcitonin receptor-like receptor’) and one of three receptor activity-modifying proteins (RAMPs) (McLatchie et al., 1998; Poyner et al., 2002).”
BackgroundCurrent trends in inflammatory and immunomodulatory mediators in sepsis
Aziz, M., Jacob, A., Yang, W.-L., Matsuda, A., & Wang, P. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0912437 · Cited by 309
“The effects of AM are mediated by the functional receptor combination of calcitonin receptor-like receptor with receptor activity-modifying protein-2 or -3 [134].”
BackgroundG-protein-coupled receptor dimerization: modulation of receptor function
Rios, C. D., Jordan, B. A., Gomes, I., & Devi, L. A. (2001) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(01)00160-7 · Cited by 309
Novel Receptor Partners and Function of Receptor Activity-modifying Proteins
Christopoulos, A., Christopoulos, G., Morfis, M., Udawela, M., Laburthe, M., Couvineau, A., Kuwasako, K., Tilakaratne, N., & Sexton, P. M. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.c200629200 · Cited by 309
Storer, R. J., Akerman, S., & Goadsby, P. J. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705807 · Cited by 307
“CGRP receptors have been difficult to characterize pharmacologically, probably due to the recently described presence of the receptor activity-modifying proteins (RAMPs) (McLatchie et al., 1998).”
BackgroundLoconto, J., Papes, F., Chang, E., Stowers, L., Jones, E. P., Takada, T., Kumánovics, A., Lindahl, K. F., & Dulac, C. (2003) · Cell · doi:10.1016/s0092-8674(03)00153-3 · Cited by 292
Hormones and Disorders of Mineral Metabolism
Bringhurst, F. R., Demay, M. B., & Kronenberg, H. M. (2011) · Williams Textbook of Endocrinology · doi:10.1016/b978-1-4377-0324-5.00028-6 · Cited by 298
Petäjä-Repo, U. E., Hogue, M., Laperrière, A., Walker, P., & Bouvier, M. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.18.13727 · Cited by 289
Characterization of two patched receptors for the vertebrate hedgehog protein family
Carpenter, D., Stone, D. M., Brush, J., Ryan, A., Armanini, M., Frantz, G., Rosenthal, A., & de Sauvage, F. J. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.23.13630 · Cited by 289
GABAB Receptors: A New Paradigm in G Protein Signaling
Couve, A., Moss, S. J., & Pangalos, M. N. (2000) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2000.0908 · Cited by 283
Regulation of transport of the dopamine D1 receptor by a new membrane-associated ER protein
Bermak, J. C., Li, M., Bullock, C., & Zhou, Q.-Y. (2001) · Nature Cell Biology · doi:10.1038/35074561 · Cited by 281
Regulation of G protein-coupled receptor export trafficking
Dong, C., Filipeanu, C. M., Duvernay, M. T., & Wu, G. (2007) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2006.09.008 · Cited by 278
Pancreatic signals controlling food intake; insulin, glucagon and amylin
Woods, S. C., Lutz, T. A., Geary, N., & Langhans, W. (2006) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2006.1858 · Cited by 277
“B (2006) (RAMPs) (McLatchie et al. 1998; Christopoulos et al. 1999; Foord & Marshall 1999; Muff et al. 1999; Sexton et al. 2001; Fischer et al. 2002).”
Dishevelled: at the crossroads of divergent intracellular signaling pathways
Boutros, M., & Mlodzik, M. (1999) · Mechanisms of Development · doi:10.1016/s0925-4773(99)00046-5 · Cited by 275
“One could speculate about a speci®city co-receptor, as shown for RAMPs as speci®city switching factors of the CGRP receptor in mammals (McLatchie et al., 1998 ).”
BackgroundOrphan G-protein-coupled receptors and natural ligand discovery
Howard, A. D., McAllister, G., Feighner, S. D., Liu, Q., Nargund, R. P., Van der Ploeg, L. H. T., & Patchett, A. A. (2001) · Trends in Pharmacological Sciences · doi:10.1016/s0165-6147(00)01636-9 · Cited by 275
Islet amyloid polypeptide: structure, function, and pathophysiology
Akter, R., Cao, P., Noor, H., Ridgway, Z., Tu, L.-H., Wang, H., Wong, A. G., Zhang, X., Abedini, A., Schmidt, A. M., et al. (2016) · Journal of Diabetes Research · doi:10.1155/2016/2798269 · Cited by 273
Efficacy at g-protein-coupled receptors
Kenakin, T. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd722 · Cited by 263
“cgi?Q=ramp*%20not%20admr%20not%20serp1%20not%20znf198%20not%2051514&ORG=Hs">RAMPs”
Identification of novel adrenomedullin in mammals: a potent cardiovascular and renal regulator
Takei, Y., Inoue, K., Ogoshi, M., Kawahara, T., Bannai, H., & Miyano, S. (2004) · FEBS Letters · doi:10.1016/s0014-5793(03)01368-1 · Cited by 268
GPCR interacting proteins (GIP)
Bockaert, J., Fagni, L., Dumuis, A., & Marin, P. (2004) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2004.06.004 · Cited by 263
Brady, A. E., & Limbird, L. E. (2002) · Cellular Signalling · doi:10.1016/s0898-6568(01)00239-x · Cited by 263
Adrenomedullin signaling is necessary for murine lymphatic vascular development
Fritz-Six, K. L., Dunworth, W. P., Li, M., & Caron, K. M. (2008) · Journal of Clinical Investigation · doi:10.1172/jci33302 · Cited by 261
“The ligand-binding affinity of CLR (and other class II GPCRs) can be changed via receptor interaction with a class of single-pass transmembrane proteins called receptor activity–modifying proteins (RAMPs) (29).”
BackgroundEftekhari, S., Warfvinge, K., Blixt, F. W., & Edvinsson, L. (2013) · The Journal of Pain · doi:10.1016/j.jpain.2013.03.010 · Cited by 260
Christ-Crain, M., & Müller, B. (2007) · European Respiratory Journal · doi:10.1183/09031936.00166106 · Cited by 251
A novel diuretic hormone receptor in Drosophila: evidence for conservation of CGRP signaling
Johnson, E. C., Shafer, O. T., Trigg, J. S., Park, J., Schooley, D. A., Dow, J. A., & Taghert, P. H. (2005) · Journal of Experimental Biology · doi:10.1242/jeb.01529 · Cited by 254
“…peptide (CGRP) and adrenomedullin (AM) both activate CLR, but their activities are defined by the co-expression of specific accessory protein sub-types called RAMPs (receptor activity modifying proteins; McLatchie et al., 1998; Buhlmann et al., 1999; Christopoulos et al., 1999; Hay et al., 2004).”
BackgroundInfluentialYang, D., Jacobson, A., Meerschaert, K. A., Sifakis, J. J., Wu, M., Chen, X., Yang, T., Zhou, Y., Anekal, P. V., Rucker, R. A., et al. (2022) · Cell · doi:10.1016/j.cell.2022.09.024 · Cited by 224
Metadata
- Authors
- McLatchie, L. M., Fraser, N. J., Main, M. J., Wise, A., Brown, J., Thompson, N., Solari, R., Lee, M. G., & Foord, S. M.
- Corresponding author
- Foord, Steven M.
- Venue
- Nature
- Published
- 1998-05
- Volume
- 393
- Issue
- 6683
- Pages
- 333-339
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W2111112233
- Cited by
- 2,134
- References
- 27
- Citations by year
- 2026: 27 · 2025: 52 · 2024: 50 · 2023: 36 · 2022: 60 · 2021: 57 · 2020: 73 · 2019: 66 · 2018: 66 · 2017: 60 · 2016: 68 · 2015: 61 · 2014: 59 · 2013: 75 · 2012: 69
- FWCI
- 40.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Open Research (University of Surrey) (submittedVersion)
- Surrey Research Insight Open Access (The University of Surrey) (submittedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuropeptides and Animal Physiology
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
- Life Sciences › Neuroscience › Sensory Systems › Ion Channels and Receptors
- Keywords
- calcitonin receptor-like receptor, receptor activity-modifying proteins, RAMP1, RAMP2, calcitonin gene-related peptide, adrenomedullin, G protein-coupled receptors, receptor trafficking, plasma membrane transport, core glycosylation, ligand specificity, peptide receptors
- MeSH terms
- Amino Acid Sequence, Animals, Biological Transport, Calcitonin, Cell Line, Cloning, Molecular, Cross-Linking Reagents, Glycosylation, Humans, Membrane Proteins, Molecular Sequence Data, Peptides, RNA, Messenger, Tumor Cells, Cultured, Xenopus, Calcitonin Gene-Related Peptide, Gene Expression, Sequence Alignment, 3T3 Cells, Mannosyl-Glycoprotein Endo-beta-N-Acetylglucosaminidase, Receptors, Peptide, Receptors, Calcitonin, Receptors, Calcitonin Gene-Related Peptide, Cystic Fibrosis Transmembrane Conductance Regulator, Intracellular Signaling Peptides and Proteins, Mice, Adrenomedullin, Receptor Activity-Modifying Proteins, Receptor Activity-Modifying Protein 1, Receptor Activity-Modifying Protein 2, Receptors, Adrenomedullin, Calcitonin Receptor-Like Protein
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.